반응 #3388

ord-00d6327228e6450289cc61943cc4bea5

반응 방정식

Cl
HCl
[Li][C](C)(C)C
tBuLi
Brc1cncnc1
5-bromopyrimidine
C1CC2=[N+](C1)CCC2.[O-][Cl+3]([O-])([O-])[O-]
1,2,3,5,6,7-hexahydropyrrolizinium perchlorate
c1ncc(C23CCCN2CCC3)cn1
oil
수율 18.0%
c1ncc(C23CCCN2CCC3)cn1
7a-(5-pyrimidinyl)-hexahydro-1H-pyrrolizine
수율 18.0%

반응 조건

온도
0°CELSIUS
상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    workup.STIRRINGstirring
  2. 2
    workup.WAITwas continued for 30 minutes
  3. 3
    workup.STIRRINGstir for 1 hour
  4. 4
    기타the phases separated
  5. 5
    추출extracted with CH2Cl2 (2×)
  6. 6
    건조dried (MgSO4)
  7. 7
    농축concentrated
  8. 8
    기타the residue was chromatographed (silica gel; CHCl3 /MeOH, 98:2)

실험 절차

A solution of 1.7M tBuLi (1.6 mL, 2.6 mmol) in pentane was added to 5-bromopyrimidine (190 mg, 1.2 mmol) in Et2O:THF (1:1, 12 mL) at -100° C. After stirring for 10 minutes, 1,2,3,5,6,7-hexahydropyrrolizinium perchlorate (500 mg, 2.4 mmol) was added to the reaction slurry, and stirring was continued for 30 minutes. The reaction mixture was then allowed to warm to 0° C. and stir for 1 hour. A solution of 2N HCl was added, and the reaction mixture was poured over Et2O and the phases separated. The aqueous phase was basified with 15% NaOH solution and extracted with CH2Cl2 (2×). The CH2Cl2 phases were combined, dried (MgSO4), concentrated, and the residue was chromatographed (silica gel; CHCl3 /MeOH, 98:2) to afford a clear oil (40 mg, 18%). MS (CI/NH3) m/e: 190 (M+H)+. 1H NMR (CDCl3, 300 MHz) δ1.60-1.73 (m, 2H), 1.82-2.11 (m, 6H), 2.66-2.75 (m, 2H), 3.15-3.21 (m, 2H), 8.85 (s, 2H), 9.05 (s,1H).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US05733912uspto-grants-1998_03